TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Brands Launches Charlotte’s Web™ CBD Gummies in Canada
07 oct. 2024 07h00 HE | Tilray Brands, Inc.
TORONTO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, announced the launch of new Charlotte's...
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Medical Launches Redecan Cannabis Brand in Australia
18 sept. 2024 07h00 HE | Tilray Brands, Inc.
Tilray's EU-GMP Certified Redecan Cannabis Now Available in Australia with Medical Prescription.
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms
09 sept. 2024 07h00 HE | Tilray Brands, Inc.
LISBON, Portugal, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the...
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Medical Announces Scientific Study on Medical Cannabis for Patients Over Age 50
09 juil. 2024 07h00 HE | Tilray Brands, Inc.
Tilray-led scientific publication examines the real-world impact of medical cannabis use on patients over the age of 50.
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Medical Announces New Scientific Publication on Age-Related Patterns of Medical Cannabis Use
03 avr. 2024 07h00 HE | Tilray Brands, Inc.
Tilray Medical announced a new Tilray led scientific publication, Age-related Patterns of medical Cannabis Use: A Survey of Authorized Patients in Canada.
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal
14 mars 2024 07h00 HE | Tilray Brands, Inc.
Tilray Medical has received approval for the first medical cannabis extract, Tilray Oral Solution THC 5 CBD 20, in Portugal.
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Provides International Cannabis Update on Milestone German Cannabis Legalization
28 févr. 2024 07h00 HE | Tilray Brands, Inc.
Tilray is bullish on the positive paradigm shift that the new German drug policy creates for the future of cannabis in Europe.
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Medical Applauds German Bundestag and Landmark Passage of Medical Cannabis Act in Germany
23 févr. 2024 10h38 HE | Tilray Brands, Inc.
Tilray Medical welcomes the opening of the German medical cannabis market and the positive paradigm shift in German drug policy.
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Medical Expands Commercial Footprint in Europe and Broadens Distribution Across the Czech Republic
06 avr. 2023 08h45 HE | Tilray Brands, Inc.
COLOGNE, Germany, April 06, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the worldwide community to live their...
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Launches ‘Take Back Control’ Platform to Provide Women With Free Medical Cannabis Resources
18 nov. 2022 07h00 HE | Tilray Brands, Inc.
LEAMINGTON, Ontario, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the...